FDA label
What is latanoprost used for?
The FDA-approved uses of latanoprost, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted latanoprost?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Latanoprost, solution/ drops
Indications and Usage, quoted from the label by Micro Labs Limited (ANDA219306). Cross-references to other label sections are left out.
Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Source: DailyMed label, set id 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f, version 2, effective January 21, 2026. NDC 42571-499, one of 11 listings for this product.
Questions
What is latanoprost used for?
The FDA label says: “Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Latanoprost
- Is Latanoprost a controlled substance?Federal schedule
- Generic for IyuzehFDA Orange Book
- Generic for XalatanFDA Orange Book
- What is Iyuzeh used for?FDA label uses
- Is Iyuzeh a controlled substance?Federal schedule
- What is Xalatan used for?FDA label uses
- Is Xalatan a controlled substance?Federal schedule
- NDC 47335-317Latanoprost NDC record
- NDC 58151-419Latanoprost NDC record
- NDC 82584-003Latanoprost NDC record